文献速递心脑血管急症

急诊科胸痛患者先进检查后主要不良心脏事件:系统评价与荟萃分析

Major adverse cardiac events after emergency department evaluation of chest pain patients with advanced testing: Systematic review and meta-analysis.
PubMed 文献 · Acad Emerg Med · 2021-11-23
一句话结论低至中危胸痛患者冠脉CTA示<50%狭窄或负荷试验阴性且心电图和肌钙蛋白无异常时,12个月内MACE低,可出院无需进一步危险分层。

该系统评价与荟萃分析纳入33篇文章,评估低至中危急性冠脉综合征患者在冠脉计算机断层扫描血管造影(cCTA)、心电图负荷试验、负荷超声心动图和心肌灌注闪烁显像(MPS)阴性后1、6、12个月的主要不良心脏事件(MACE)风险。1个月cCTA汇总MACE为0.09%(95%CI 0.03%–0.26%),运动负荷试验为0.23%(95%CI 0.01%–5.8%)(p=1);6个月MPS和cCTA总体事件率为0.15%(95%CI 0.06%–0.41%)(I²=0%);12个月cCTA汇总MACE为0.16%(95%CI 0.04%–0.65%),负荷超声心动图为1.68%(95%CI 0.01%–2.6%),组内异质性低(I²=0%)。cCTA无病变与非阻塞性病变(<50%狭窄)亚组在1个月和12个月MACE均无统计学差异。作者结论认为,胸痛患者若cCTA示<50%狭窄、心电图负荷试验、负荷超声心动图或负荷心肌灌注扫描阴性(过去12个月内),且心电图和肌钙蛋白无异常,可出院无需进一步危险分层。

要点

  • 低至中危胸痛患者cCTA阴性后1个月汇总MACE为0.09%(95%CI 0.03%–0.26%),运动负荷试验为0.23%(95%CI 0.01%–5.8%),两者比较p=1。
  • 6个月MPS和cCTA总体事件率为0.15%(95%CI 0.06%–0.41%),异质性I²=0%。
  • 12个月cCTA汇总MACE为0.16%(95%CI 0.04%–0.65%),负荷超声心动图为1.68%(95%CI 0.01%–2.6%),组内异质性低(I²=0%)。
  • cCTA无病变与非阻塞性病变(<50%狭窄)亚组1个月MACE分别为0.17%(95%CI 0.04%–0.67%)和0.06%(95%CI 0.01%–0.34%),12个月分别为0.44%(95%CI 0.09%–2.2%)和0.54%(95%CI 0.19%–1.5%),均无统计学差异。
  • 作者认为,cCTA示<50%狭窄、负荷试验阴性(过去12个月内)且心电图和肌钙蛋白无异常的低至中危胸痛患者可出院,无需进一步危险分层。

适用人群与场景

  • 低至中危急性冠脉综合征(ACS)患者,因胸痛在急诊科接受评估。
  • 纳入标准:风险分层为低至中危,接受标准检查(cCTA、心电图负荷试验、负荷超声心动图或MPS)。

诊断标准与关键阈值

  • cCTA显示无病变或非阻塞性病变(<50%狭窄)。
  • 心电图负荷试验、负荷超声心动图或负荷心肌灌注扫描阴性(过去12个月内)。
  • 心电图和肌钙蛋白无异常(reassuring)。

处置流程与药物剂量

  • 对于低至中危胸痛患者,若cCTA示<50%狭窄、或心电图负荷试验、负荷超声心动图、负荷心肌灌注扫描阴性(过去12个月内),且心电图和肌钙蛋白无异常,作者认为可出院,无需进一步危险分层。

研究设计与关键结果

  • 研究类型:系统评价与荟萃分析;初筛952篇文章,81篇全文审查,最终33篇纳入分析。
  • 共21项研究评估1个月随访:cCTA汇总MACE为0.09%(95%CI 0.03%–0.26%),运动负荷试验为0.23%(95%CI 0.01%–5.8%),p=1。
  • 6个月时MPS和cCTA总体事件率为0.15%(95%CI 0.06%–0.41%),异质性I²=0%。
  • 12个月亚组分析:cCTA汇总MACE为0.16%(95%CI 0.04%–0.65%),负荷超声心动图为1.68%(95%CI 0.01%–2.6%),组内异质性低(I²=0%)。
  • cCTA亚组分析(无病变 vs 非阻塞性病变<50%狭窄):1个月MACE分别为0.17%(95%CI 0.04%–0.67%)和0.06%(95%CI 0.01%–0.34%),无统计学差异;12个月分别为0.44%(95%CI 0.09%–2.2%)和0.54%(95%CI 0.19%–1.5%),无统计学差异。
  • 采用随机效应模型评估汇总MACE事件比例;异质性分析使用Cochrane Q检验和I²统计量。

证据类型、等级与局限

  • 证据类型:系统评价与荟萃分析。
  • 偏倚风险评估后纳入33篇文章。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于低至中危胸痛患者,若cCTA示<50%狭窄、或心电图负荷试验、负荷超声心动图、负荷心肌灌注扫描阴性(过去12个月内),且心电图和肌钙蛋白无异常,作者认为可出院,无需进一步危险分层。

指南或共识出处

  • 来源期刊:Academic Emergency Medicine。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Our primary objective was to describe the risk of major adverse cardiac events (MACE) at 1, 6, and 12 months after a negative coronary computed tomography angiogram (cCTA), electrocardiogram (ECG) stress test, stress echocardiography, and myocardial perfusion scintigraphy (MPS) in low- to intermediate-risk patients.

METHODS: Initially, 952 articles were identified for screening, 81 met criteria for full-text review, and once risk of bias was assessed, 33 articles were included in this meta-analysis. We utilized a random-effects model to assess pooled MACE event proportion for patients undergoing evaluation of acute coronary syndrome (ACS) when risk stratified to a low- to intermediate-risk category after undergoing standard testing. Heterogeneity analysis was performed using Cochrane's Q-test and I2 statistic.

RESULTS: Twenty-one studies evaluated follow-up at 1 month with cCTA having a 0.09% (95% confidence interval [CI] = 0.03% to 0.26%) pooled MACE compared to 0.23% (95% CI = 0.01% to 5.8%) of the exercise stress testing (p = 1). MPS and cCTA had an overall event rate of 0.15% (95% CI = 0.06% to 0.41%) at 6 months (I2 = 0%). At 12 months, a subgroup analysis found a pooled cCTA MACE of 0.16% (95% CI = 0.04% to 0.65%) compared to 1.68% (95% CI = 0.01% to 2.6%) for stress echocardiography with low within-group heterogeneity (I2 = 0%). Subgroup analysis of cCTA with no disease versus nonobstructive disease (<50% stenosis) did not find statistical difference in the MACE at both 1 month (0.17% [95% CI = 0.04% to 0.67%] vs. 0.06% [95% CI = 0.01% to 0.34%]) and 12 months (0.44% [95% CI = 0.09% to 2.2% vs. 0.54% [95% CI = 0.19% to 1.5%]).

CONCLUSIONS: Patients presenting with chest pain who have a coronary CTA showing < 50% stenosis, negative ECG stress test, stress echocardiography, or stress myocardial perfusion scan in the past 12 months can be discharged without any further risk stratification if their ECG and troponin are reassuring given low MACE.

来源:Acad Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Mehta P, McDonald S, Hirani R, et al. Major adverse cardiac events after emergency department evaluation of chest pain patients with advanced testing: Systematic review and meta-analysis. Acad Emerg Med. 2021. PMID: 34741781. doi:10.1111/acem.14407

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。